vtRNA1-1/p62

Minxin Jiang1, Jianping Ni1, Xueying Yu1

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China; The Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China.

Molecular immunology
|March 8, 2026
PubMed
概括

这项研究表明,降低vtRNA1-1和p62水平与AS患者的自功能障碍和炎症有关. 这个vtRNA1-1/p62轴为AS提供了潜在的新诊断和治疗策略.